选择地区语言
It screens for pathogenic genes associated with hereditary tumors to predict cancer risk, helping individuals proactively prevent high-risk tumors through early screening, early detection, and early treatment. Approximately 5% to 10% of cancers are linked to hereditary gene mutations—including breast cancer, colorectal cancer, endometrial cancer, and gastric cancer, many of which show obvious familial clustering. Genetic risk testing provides a reference for cancer patients and their family members to manage familial cancer risks.
Platform Advantages
SE75 sequencing takes only 4.5 h, the competitive sequencing speed will keep your project running more smoothly.
Sequencers, flow cells and reagents are self-developed and produced in-house, ensuring reliable delivery.
Building on the company’s years of expertise in microbiology, this platform includes a database of over 20,000 microbial species.
Compatible with mainstream libraries on the market, eliminating debugging costs.
Sikun Integrated NGS Solution
Integrates Extraction, Library Construction, and Quality Control in One System.
Eliminates Tedious Operational Procedures, Ultra-Simple Operation.
Reduces analysis time to accelerate
critical clinical and research decisions.
